I2SOFT(BJ:830799)2022-10-26 16:00Financial Performance - Operating revenue for the first nine months of 2022 reached CNY 408,627,747.56, representing a 42.62% increase year-over-year[15]. - Net profit attributable to shareholders for the first nine months of 2022 was CNY 31,502,439.27, a slight increase of 0.52% compared to the same period last year[15]. - Operating revenue for the third quarter of 2022 was CNY 155,677,696.91, a 49.74% increase compared to CNY 103,966,125.35 in the same quarter of the previous year[15]. - The total profit for the first nine months of 2022 was CNY 20,912,549.02, down from CNY 35,970,669.42 in the same period of 2021, representing a decline of 41.8%[78]. - Net profit for Q3 2022 was ¥14,412,927.82, compared to ¥13,130,650.12 in Q3 2021, marking an increase of 9.7%[74]. Assets and Liabilities - Total assets as of September 30, 2022, amounted to CNY 688,487,637.49, reflecting a 0.67% increase compared to the end of the previous year[15]. - The company’s total liabilities to assets ratio (consolidated) as of September 30, 2022, was 50.87%, up from 49.91% at the end of the previous year[15]. - Total liabilities increased to CNY 350,249,531.37 from CNY 341,320,920.65, indicating a growth of about 2.7%[69]. - The company's equity decreased slightly to CNY 338,238,106.12 from CNY 342,592,162.52, a decline of approximately 1.3%[69]. - The company reported a short-term loan of CNY 227,901,699.72, up from CNY 195,251,702.31, reflecting an increase of about 16.7%[68]. Cash Flow - The company reported a significant decline in net cash flow from operating activities, with a net outflow of CNY 121,400,693.27, a decrease of 163.45% year-over-year[15]. - Cash outflow for purchasing goods and services increased by 63.14% year-on-year, primarily due to increased hardware procurement[19]. - Cash inflow from investment recoveries increased by 66.58% year-on-year, rising by 103 million yuan, mainly due to the maturity of time deposits[19]. - The ending cash and cash equivalents balance decreased to 106,886,019.98 yuan from 160,979,379.24 yuan in 2021, a drop of approximately 33.6%[84]. - Cash inflow from borrowing was 305,000,000.00 yuan, compared to 194,950,000.00 yuan in 2021, marking an increase of about 56.6%[84]. Expenses - Sales expenses for the first nine months of 2022 increased by 32.88% year-on-year, with a 37.32% increase in Q3, primarily due to business growth and new sales expenses for Liyang software amounting to nearly 500,000 yuan[19]. - Management expenses for the first nine months of 2022 rose by 42.75% year-on-year, with a 47.04% increase in Q3, mainly due to new management expenses for Liyang software close to 4.8 million yuan and increased office renovation costs[19]. - R&D expenses for the first nine months of 2022 grew by 40.85% year-on-year, with a 41.10% increase in Q3, primarily due to new R&D expenses for Liyang software of approximately 8.3 million yuan and salary increases for R&D personnel[19]. - Financial expenses for the first nine months of 2022 surged by 702.36%, increasing by 3.8 million yuan, with a 389.64% increase in Q3, mainly due to increased use of short-term loans impacted by the pandemic[19]. Shareholder Commitments - The company has committed to avoiding any business activities that may compete with its operations, as per the commitments made by shareholders and executives prior to listing[38]. - The controlling shareholders Zhang Yan and Wu Zhen committed to not transferring or entrusting the management of their shares for 12 months after the company enters the selected layer[40]. - The commitments made by shareholders are irrevocable and will not be affected by changes in their positions or departure from the company[42]. - If any commitments are proven untrue or not complied with, the proceeds from the sale of shares will belong to the company[42]. - The company will ensure compliance with all relevant laws and regulations regarding share transfers and lock-up periods[41]. Research and Development - The company has committed to enhancing its research and development capabilities to improve product and service offerings[52]. - Research and development expenses for Q3 2022 were ¥20,135,999.43, up from ¥14,270,488.32 in Q3 2021, representing a 41.1% increase[73]. - Research and development expenses increased to CNY 40,435,185.47 in the first nine months of 2022, up from CNY 33,605,949.86 in the same period of 2021, indicating a growth of 20.5%[77]. Investment and Profit Distribution - The company plans to enhance investment returns by ensuring the implementation of fundraising projects, which are expected to significantly improve profitability[52]. - The company has established a profit distribution policy to ensure reasonable returns for investors, including a commitment to cash dividends[54]. - The company has pledged to repay investors in case of any losses caused by false statements or omissions in the stock issuance documentation[55].